Cortistatin 29 (1-13) is an N-terminal fragment used to investigate structural determinants shared with somatostatin-like peptides. Its short sequence supports studies of motif conservation and receptor interaction. Researchers analyze its conformation to characterize early folding events. The peptide contributes to understanding cortistatin-derived signaling elements.
CAT No: C30001
1. Myotropic activity of allatostatins in tenebrionid beetles
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More